Skip to main content
. 2010 Dec 14;16(46):5881–5888. doi: 10.3748/wjg.v16.i46.5881

Figure 3.

Figure 3

Overall survival time of patients with or without KRAS mutation (A) and phosphatase and tensin protein expression and skin toxicity (B). A: P < 0.001; B: P = 0.004. OS: Overall survival.